Tongnuokang is a pharmaceutical service provider, focusing on medical research and experimental development, cell technology research and development and application, sales of first-class medical devices, and sales of experimental analytical instruments. Recently, Dynamic Balance Capital completed the lead investment in Tongnuokang’s angel round. This round of financing will be used for R&D pipeline advancement, AI platform upgrade and team building.
This article is reproduced from: https://www.itjuzi.com/investevent/13543641
This site is for inclusion only, and the copyright belongs to the original author.